Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Overview Of Value Stocks In The Healthcare Sector

Author: Benzinga Insights | November 27, 2023 10:43am

Understanding Value Stocks

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

The following stocks are considered to be notable value stocks in the healthcare sector:

  1. First Wave BioPharma (NASDAQ:FWBI) - P/E: 0.0
  2. Kiora Pharmaceuticals (NASDAQ:KPRX) - P/E: 0.71
  3. TherapeuticsMD (NASDAQ:TXMD) - P/E: 0.61
  4. Voyager Therapeutics (NASDAQ:VYGR) - P/E: 5.89
  5. Organon (NYSE:OGN) - P/E: 4.98

First Wave BioPharma has reported Q2 earnings per share at $-1.89, which has decreased by 3.85% compared to Q1, which was -1.82. Kiora Pharmaceuticals has reported Q3 earnings per share at $-0.89, which has decreased by 12.66% compared to Q2, which was -0.79. TherapeuticsMD saw an increase in earnings per share from -0.24 in Q2 to $-0.13 now. Voyager Therapeutics saw a decrease in earnings per share from -0.51 in Q2 to $-0.59 now. This quarter, Organon experienced a decrease in earnings per share, which was $1.31 in Q2 and is now $0.87. Its most recent dividend yield is at 7.65%, which has increased by 2.51% from 5.14% in the previous quarter.

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

Posted In: FWBI KPRX OGN TXMD VYGR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist